News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

South Texas Accelerated Research Therapeutics and Cenova Form JV for China Cancer Phase I Trial Facility


2/3/2011 3:13:01 PM

February 3, 2011 -- START (South Texas Accelerated Research Therapeutics) announced a joint venture that will open a Phase I clinical trial facility specifically for cancer patients in Fudan University Shanghai Cancer Center (FUSCC). START’s partner in the initiative is Cenova Ventures, an RMB venture capital firm with backing from both national and local government. More details....

Read at BioSpace.com
Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES